Rituximab monotherapy, rather than rituximab plus antiviral drugs, for initial treatment of severe hepatitis C virus-associated mixed cryoglobulinemia syndrome: comment on the article by Terrier et al

Arthritis Rheum. 2010 Mar;62(3):908-9; author reply 909. doi: 10.1002/art.27310.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antiviral Agents / administration & dosage*
  • Cryoglobulinemia / complications*
  • Drug Therapy, Combination
  • Hepatitis C / complications*
  • Hepatitis C / drug therapy*
  • Humans
  • Rituximab
  • Syndrome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antiviral Agents
  • Rituximab